Phase 1 trial of exercise as first-line therapy for hormone receptor (HR)–positive advanced breast cancer (TBCRC 054).

Authors: Neil M. Iyengar, Jessica A. Lavery, Adele Carlson, Vanessa Castillo, Sarah Lehman, Meghan G. Michalski, Jenna Harrison, Alexis Braun, Jessica Flores, Su Chun, Catherine P. Lee, Jesus Del Santo Anampa, Tarah Jean Ballinger, Jennifer Y. Sheng, Chaya S. Moskowitz, Lee W. Jones

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.1088

Source: Full article

---

Abstract

1088